What is Tirzepatide?

Tirzepatide is a synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been developed specifically for research applications investigating metabolic pathways, insulin signalling, and glucose regulation mechanisms in vitro. This compound is supplied in a lyophilised format to preserve molecular stability and deliver consistent research performance.

Research Applications

• Investigation of incretin hormone pathways
• Studies involving GIP and GLP-1 receptor activation
• Analysis of peptide-receptor interactions in metabolic signalling
• Research into glucose and insulin response mechanisms

Key Features

• Dual GIP/GLP-1 receptor research peptide
• Available in 10 mg and 20 mg vials
• Research-grade purity: ≥98% (HPLC verified)
• Stable lyophilised formulation for extended shelf life
• Manufactured to ensure consistency and laboratory reproducibility

Specifications

Reconstitution & Handling

• Reconstitute using sterile bacteriostatic water or another suitable laboratory solvent.
• Gently swirl until fully dissolved; avoid foaming or vigorous agitation.
• Aliquot into sterile containers if necessary to prevent degradation from freeze–thaw cycles.

Quality & Testing

Each batch of Tirzepatide provided by Power Peptides undergoes high-performance liquid chromatography (HPLC) analysis and mass spectrometry verification to confirm molecular identity and purity. Batch-specific Certificates of Analysis (COAs) are available upon request.

Storage Guidelines

• Unopened vials: Store at –20 °C in a light-protected environment.
• After reconstitution: Store at 2–8 °C and use as soon as possible for optimal stability.

Important Notice

For laboratory research use only. This compound is not intended for human or veterinary use, clinical testing, or medical applications. The purchaser is responsible for ensuring all appropriate laboratory handling procedures and regulatory compliance.